American Century Companies’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.7M Sell
355,854
-1,446
-0.4% -$78.5K 0.01% 1171
2025
Q4
$16.5M Buy
357,300
+13,273
+4% +$594K 0.01% 1248
2025
Q3
$12.4M Sell
344,027
-7,025
-2% -$233K 0.01% 1347
2025
Q2
$11.4M Sell
351,052
-236,002
-40% -$7.74M 0.01% 1320
2025
Q1
$22.2M Sell
587,054
-18,213
-3% -$1.46M 0.01% 995
2024
Q4
$49.5M Buy
605,267
+76,262
+14% +$7.57M 0.03% 628
2024
Q3
$60.4M Buy
529,005
+1,411
+0.3% +$127K 0.04% 527
2024
Q2
$39.8M Buy
527,594
+65,870
+14% +$4.48M 0.02% 660
2024
Q1
$31.5M Buy
461,724
+54,495
+13% +$3.77M 0.02% 740
2023
Q4
$25.6M Buy
407,229
+35,487
+10% +$1.84M 0.02% 777
2023
Q3
$19M Buy
371,742
+9,099
+3% +$449K 0.01% 823
2023
Q2
$18.1M Buy
+362,643
New +$17.2M 0.01% 818
2023
Q1
Sell
-8,062
Closed -$387K 2686
2022
Q4
$387K Buy
+8,062
New +$316K ﹤0.01% 2136

Other funds holding PCVX